Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Urinary Tract Calculi VI: Surgical Management01:25

Urinary Tract Calculi VI: Surgical Management

Procedures for Kidney StonesMedical intervention is necessary when kidney stones or renal calculi are too large to pass spontaneously (typically greater than 5 millimeters) when stones are accompanied by symptomatic infection (such as fever or pyelonephritis), when they impair kidney function, or when they cause persistent symptoms like severe pain, nausea, or urinary retention. Additionally, patients with only one kidney or those who cannot be treated with medical management also require...
Urinary Tract Calculi III: Medical Management01:30

Urinary Tract Calculi III: Medical Management

The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Response to "Comment on 'Symptom Relief and Practice Setting Variation in Bulkamid Injections for Stress Urinary Incontinence'".

Neurourology and urodynamics·2026
Same author

Frailty, Bone Health, and Radiographic Predictors of Complications After Long-Segment Fusion for Adult Spinal Deformity.

World neurosurgery·2026
Same author

Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline (2026) Part III: Procedural/Surgical Management.

The Journal of urology·2026
Same author

Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline (2026) Part II: Medical Management.

The Journal of urology·2026
Same author

Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline (2026) Part I: Presentation and Evaluation.

The Journal of urology·2026
Same author

Symptom Relief and Practice Setting Variation in Bulkamid Injections for Stress Urinary Incontinence.

Neurourology and urodynamics·2026
Same journal

Response to Letter to the Editor re: "Factors Associated With Persistent Bothersome Urinary Symptoms and Leakage After Pregnancy".

Urogynecology (Philadelphia, Pa.)·2026
Same journal

Methodological Considerations in Postpartum Urinary Incontinence: Addressing Occupational and Clinical Confounders.

Urogynecology (Philadelphia, Pa.)·2026
Same journal

Response to Letter to the Editor re: "Nocturnal Polyuria and MACE: Neuroendocrine Links Explaining Sex Differences" and "Nocturia and Cardiovascular Events: Risk Factor or Clinical Marker?"

Urogynecology (Philadelphia, Pa.)·2026
Same journal

Nocturnal Polyuria and MACE: Neuroendocrine Links Explaining Sex Differences.

Urogynecology (Philadelphia, Pa.)·2026
Same journal

Nocturia and Cardiovascular Events: Risk Factor or Clinical Marker?

Urogynecology (Philadelphia, Pa.)·2026
Same journal

Letter to the Editor re: Using Chatbot to Better Understand What Matters Most to Urogynecologic Patients.

Urogynecology (Philadelphia, Pa.)·2026
See all related articles

Related Experiment Video

Updated: May 14, 2026

Vessel-sparing Excision and Primary Anastomosis
08:09

Vessel-sparing Excision and Primary Anastomosis

Published on: January 7, 2019

Bulkamid for Recurrent SUI After Suburethral Sling Revision: Single-Center Study.

Christina Sze1, Carolina Martinez Fernandez2, Maali LaFrance2

  • 1Department of Urology, University of Texas Southwestern Medical Center.

Urogynecology (Philadelphia, Pa.)
|May 12, 2026
PubMed
Summary
This summary is machine-generated.

Bulkamid injections effectively treat recurrent stress urinary incontinence (SUI) after sling revision, particularly for isolated SUI. This minimally invasive option offers significant symptom improvement for many patients.

More Related Videos

Transcorporal Artificial Urinary Sphincter Cuff Placement in a Case Requiring Revision for Urethral Atrophy
03:25

Transcorporal Artificial Urinary Sphincter Cuff Placement in a Case Requiring Revision for Urethral Atrophy

Published on: June 16, 2022

Urethral Stricture Induction Followed by Buccal Mucosa Graft Urethroplasty in a Rat Model
05:09

Urethral Stricture Induction Followed by Buccal Mucosa Graft Urethroplasty in a Rat Model

Published on: April 28, 2023

Related Experiment Videos

Last Updated: May 14, 2026

Vessel-sparing Excision and Primary Anastomosis
08:09

Vessel-sparing Excision and Primary Anastomosis

Published on: January 7, 2019

Transcorporal Artificial Urinary Sphincter Cuff Placement in a Case Requiring Revision for Urethral Atrophy
03:25

Transcorporal Artificial Urinary Sphincter Cuff Placement in a Case Requiring Revision for Urethral Atrophy

Published on: June 16, 2022

Urethral Stricture Induction Followed by Buccal Mucosa Graft Urethroplasty in a Rat Model
05:09

Urethral Stricture Induction Followed by Buccal Mucosa Graft Urethroplasty in a Rat Model

Published on: April 28, 2023

Area of Science:

  • Urology
  • Female Pelvic Medicine and Reconstructive Surgery

Background:

  • Postoperative stress urinary incontinence (SUI) after suburethral sling revision is a common complication impacting quality of life.
  • Polyacrylamide hydrogel (PAHG), marketed as Bulkamid, presents a minimally invasive treatment option for recurrent SUI, though data in this specific patient group is limited.

Purpose of the Study:

  • To assess the safety and efficacy of Bulkamid injections for persistent or recurrent SUI following suburethral sling revision.
  • To identify factors influencing treatment response in patients undergoing Bulkamid injections for post-sling revision SUI.

Main Methods:

  • Retrospective, single-center study of 41 women treated with Bulkamid for SUI or stress-predominant mixed urinary incontinence (MUI) after sling revision (2019-2024).
  • Incontinence severity evaluated using pad usage, Urogenital Distress Inventory-6 (UDI-6), Incontinence Impact Questionnaire-7 (IIQ-7), and patient-reported outcomes.
  • Statistical analysis included nonparametric and categorical methods with significance set at P<0.05.

Main Results:

  • Median pad use decreased significantly post-injection (2 to 0, P=0.01).
  • UDI-6 scores improved significantly (median 66.7 to 44.4, P=0.005), with notable improvements in urinary frequency and pain.
  • Symptom improvement was significant for SUI only (P=0.016) but not for MUI (P=0.258).

Conclusions:

  • Bulkamid injection is a safe and effective minimally invasive treatment for recurrent SUI after suburethral sling revision.
  • Patients with isolated SUI and those receiving a single injection experienced the greatest benefit.
  • Mixed urinary incontinence or prior synthetic slings may be associated with reduced treatment efficacy.